CRMP5-IgG–Associated Paraneoplastic Myelopathy With PD-L1 Inhibitor Therapy
Authors:
- 1 February 2020
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 77 (2) , 255-256
Abstract
This case report describes CRMP5-IgG–associated paraneoplastic myelopathy with PD-L1 inhibitor therapy in a woman in her 60s.Keywords
This publication has 3 references indexed in Scilit:
- Curing Multiple Sclerosis: How to Know When We're ThereAnnals of Neurology, 2021
- Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectivesNature Reviews Neurology, 2017
- Paraneoplastic isolated myelopathyNeurology, 2011